☆ 4.6 Meeting Abstract

A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies

JOURNAL OF THORACIC ONCOLOGY (2017)

Journal

JOURNAL OF THORACIC ONCOLOGY

Volume 12, Issue 1, Pages S292-S293

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.jtho.2016.11.300

Keywords

Mesothelioma; Nivolumab; Immunotherapy; translational research

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.